|1.||Duncan, Ruth: 6 articles (06/2011 - 04/2008)|
|2.||Ferguson, Elaine L: 5 articles (04/2015 - 09/2008)|
|3.||Thomas, David W: 5 articles (04/2015 - 09/2008)|
|4.||Moseley, Ryan: 3 articles (06/2011 - 09/2008)|
|5.||Manchun, Somkamol: 2 articles (08/2015 - 12/2014)|
|6.||Guérin-Deremaux, Laetitia: 2 articles (08/2015 - 09/2011)|
|7.||Cheewatanakornkool, Kamonrak: 2 articles (08/2015 - 12/2014)|
|8.||Dass, Crispin R: 2 articles (08/2015 - 12/2014)|
|9.||Sriamornsak, Pornsak: 2 articles (08/2015 - 12/2014)|
|10.||Limem, Khalifa: 2 articles (03/2012 - 01/2011)|
|1.||Wounds and Injuries (Trauma)
06/30/2011 - "In this established impaired wound healing model, the topically-applied dextrin-rhEGF significantly accelerated wound closure and neo-dermal tissue formation at the macroscopic level; and significantly increased granulation tissue deposition and angiogenesis at the histological level (p<0.05), relative to untreated, succinoylated dextrin and rhEGF alone controls. "
06/30/2011 - "Standardised, full-thickness excisional wounds, created in the dorsal flank skin, were treated topically with succinoylated dextrin (50 μg/mL), rhEGF (10 μg/mL) or dextrin-rhEGF (1 or 10 μg/mL). "
06/30/2011 - "The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse."
06/07/2010 - "Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds."
09/24/2008 - "Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair."
09/01/1994 - "1. Structural analogues of a sulphated polysaccharide, dextrin sulphate, were synthesized and tested for their ability to block infection by HIV-1. "
09/01/1994 - "Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells."
01/01/2006 - "Here we have evaluated two candidate polyanion compounds in clinical trials, PRO 2000 and dextrin sulphate (DxS) to determine their safety and efficacy against in vitro HIV-1 and HSV-2 infection using cellular and tissue explant models. "
04/01/2015 - "These studies confirm the utility of this model system to simulate the pharmacokinetics of colistin formation in humans administered dextrin-colistin conjugates and further supports the development of antibiotic polymer conjugates in the treatment of MDR infections. "
05/21/2009 - "The dextrin II-trypsin conjugate was more stable than the other conjugates and native trypsin at all temperatures between 30 and 70 degrees C, and also exhibited improved thermal stability in the autolysis assays at 40 degrees C."
05/21/2009 - "Dextrin-trypsin and ST-HPMA-trypsin conjugates: enzyme activity, autolysis and thermal stability."
05/21/2009 - "As we are currently developing dextrin- and semi-telechelic poly[N-(2-hydroxypropyl)methacrylamide] (ST-HPMA)-protein conjugates as new therapeutics, the aim of this study was to examine the effect of polymer on activity, autolysis and its thermal stability using trypsin conjugates as a model and compare to the data obtained for mPEG conjugates. "
10/15/2015 - "We hypothesized that the incorporation of LLKKK18 conjugated to dextrin would improve the healing process in rat burns. "
10/15/2015 - "Improved burn wound healing by the antimicrobial peptide LLKKK18 released from conjugates with dextrin embedded in a carbopol gel."
04/01/2015 - "Incubation of dextrin-colistin conjugates with infected wound exudate from a series of burn patients (n = 6) revealed an increasing concentration of unmasked colistin in the outer compartment (OC) over time (up to 86.3% of the initial dose at 48 h), confirming that colistin would be liberated from the conjugate by endogenous α-amylase within the wound environment. "
09/01/1997 - "In coronal frozen sections through parietal cortex labeled immunohistochemically for glial fibrillary acidic protein, the pups exposed to alcohol by intubation had a significantly greater density of glial fibrillary acidic protein-positive astrocytes per unit volume, compared with littermate controls intubated with a maltose-dextrin formula; alcohol also induced fibrillary hypertrophy of the labeled astrocytes. "
|2.||PRO 2000 (PRO-2000)
|6.||Epidermal Growth Factor (EGF)
|7.||Glial Fibrillary Acidic Protein
|4.||Fluid Therapy (Oral Rehydration Therapy)